Koenig C, Turnicky R P, Kankam C F, Tavassoli F A
Department of Gynecologic and Breast Pathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000, USA.
Am J Surg Pathol. 1997 Aug;21(8):915-21. doi: 10.1097/00000478-199708000-00005.
Papillary carcinomas of the uterine cervix with transitional or squamous differentiation are rare tumors that often resemble transitional cell carcinomas of the urinary tract. We reviewed 32 such cases of papillary cervical carcinoma and divided them into three groups: 1) predominantly (> 90%) squamous (nine cases), 2) mixed squamous and transitional (16 cases), and 3) predominantly transitional (seven cases). Overall, the patients ranged in age from 22 to 93 years (mean 50), and the most common clinical presentation was abnormal bleeding (15 patients) and an abnormal Papanicolaou smear (nine patients). The tumors ranged in size from 0.7 to 6.0 cm (mean 3.0). All cases demonstrated a papillary architecture with fibrovascular cores lined by a multilayered, atypical epithelium resembling a high-grade squamous intraepithelial lesion of the cervix. Underlying superficial to deep stromal invasion was seen in 18 of 20 cases (90%); in the remaining 12 cases, the specimen was too superficial to assess invasion. Eighteen (86%) of the 21 cases examined immunohistochemically demonstrated immunoreactivity for cytokeratin 7, whereas only two of the 21 (9.5%) showed positivity for cytokeratin 20. Of the 12 women for whom follow-up information was available, three were treated by simple hysterectomy, two underwent radical hysterectomy, one was treated with radiation alone, and one with combination chemotherapy and radiotherapy. Three patients died of disease (two in the squamous group and one transitional) within an average of 13 months after diagnosis. Local recurrence developed in two women, and one of these, a vaginal recurrence, occurred 12 years after the original diagnosis. Based on the above findings, we believe that these tumors are a clinicopathologically distinct, homogeneous group that display a morphologic spectrum. Nevertheless, because some tumors may show a purely squamous or purely transitional appearance, we propose retaining the above three separate designations for these tumors with the understanding that there is often a substantial degree of subjectivity in deciding whether a tumor is squamous or transitional. The most distinctive, objective, and easily recognizable feature of these tumors is their surface papillary architecture rather than their superficial resemblance to transitional cell carcinomas of the urinary tract, and we emphasize the need to distinguish these potentially aggressive malignant tumors from the far more common and benign papillary lesions of the cervix.
具有移行或鳞状分化的子宫颈乳头状癌是罕见肿瘤,常类似泌尿道移行细胞癌。我们回顾了32例此类子宫颈乳头状癌病例,并将其分为三组:1)主要为(>90%)鳞状(9例),2)鳞状和移行混合(16例),3)主要为移行(7例)。总体而言,患者年龄在22至93岁之间(平均50岁),最常见的临床表现是异常出血(15例患者)和巴氏涂片异常(9例患者)。肿瘤大小在0.7至6.0 cm之间(平均3.0 cm)。所有病例均显示乳头结构,纤维血管轴心衬以多层非典型上皮,类似子宫颈高级别鳞状上皮内病变。20例中有18例(90%)可见从浅到深的间质浸润;其余12例标本过浅无法评估浸润情况。免疫组化检查的21例中有18例(86%)细胞角蛋白第7呈免疫反应性,而21例中只有2例(9.5%)细胞角蛋白第20呈阳性。在有随访信息的12例女性中,3例行单纯子宫切除术,2例行根治性子宫切除术,1例仅接受放疗,1例接受化疗和放疗联合治疗。3例患者在诊断后平均13个月内死于疾病(鳞状组2例,移行组1例)。2例女性出现局部复发,其中例阴道复发发生在原诊断后12年。基于上述发现,我们认为这些肿瘤是一组临床病理特征独特、形态谱一致的肿瘤。然而,由于一些肿瘤可能呈现纯粹的鳞状或纯粹的移行外观,我们建议保留上述三种对这些肿瘤的分类名称,但要明白在判断肿瘤是鳞状还是移行时往往存在很大程度的主观性。这些肿瘤最显著、客观且易于识别的特征是其表面乳头结构,而非与泌尿道移行细胞癌的表面相似性,我们强调需要将这些潜在侵袭性恶性肿瘤与子宫颈更为常见的良性乳头状病变区分开来。